Chinese english Germany Japanese Korea

6-cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H-1l3-[1,3]dioxino[5,6-c]quinoline-2,2-diyl diacetate

6-cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H-1l3-[1,3]dioxino[5,6-c]quinoline-2,2-diyl diacetate Struktur
139693-52-0
CAS-Nr.
139693-52-0
Englisch Name:
6-cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H-1l3-[1,3]dioxino[5,6-c]quinoline-2,2-diyl diacetate
Synonyma:
Moxifloxacin-8;BALOFLOXACIN CHELATE;Moxifloxacin Impurity I;Moxifloxacin EP Imp.INT-1;6-cyclopropyl-8,9-difluoro;Moxifloxacin Impurity INT-1;Moxifloxacin Intermediate I;Moxifloxacin Impurity 12 CRS;Azilsartan medoxomil impurity284;Moxifloxacin Boron Complex Impurity
CBNumber:
CB43051762
Summenformel:
C18H16BF2NO8
Molgewicht:
423.13
MOL-Datei:
139693-52-0.mol
Request For Quotation

6-cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H-1l3-[1,3]dioxino[5,6-c]quinoline-2,2-diyl diacetate Eigenschaften

Sicherheit

6-cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H-1l3-[1,3]dioxino[5,6-c]quinoline-2,2-diyl diacetate Chemische Eigenschaften,Einsatz,Produktion Methoden

6-cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H-1l3-[1,3]dioxino[5,6-c]quinoline-2,2-diyl diacetate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Triacetoxyboron oxo(oxoboranyloxy)borane 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester Borsure Essigsäureanhydrid

Downstream Produkte

6-cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H-1l3-[1,3]dioxino[5,6-c]quinoline-2,2-diyl diacetate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 65)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
career henan chemical co 		+86-0371-86658258 15093356674;
 factory@coreychem.com China 29826 58
AFINE CHEMICALS LIMITED 		0571-85134551 18958018566;
 info@afinechem.com China 15377 58
Hangzhou Huarong Pharm Co., Ltd. 		571-86758373 +8613588754946
 sales@huarongpharm.com CHINA 3149 58
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
Shanghai Payne Pharmaceutical Technology Co.Ltd 		021-58123769 18678586262
 info@paynepharm.com China 1354 58
BOC Sciences 1-631-485-4226; 16314854226
 info@bocsci.com United States 14059 65
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-4000505016 13380397412
 3001272453@qq.com China 4967 50
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-52878169 15701683040
 sales@bjcomparison.com China 4704 58
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
 sales@chem-strong.com China 17993 56
Wuxi Zhongkun Biochemical Technology Co., Ltd. 0510-85629785 18013409632
 sales@reading-chemicals.com China 15185 58

139693-52-0()Verwandte Suche:

Ethylfumarat
  • 6-cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H-1l3-[1,3]dioxino[5,6-c]quinoline-2,2-diyl diacetate
  • Moxifloxacin Impurity I
  • Moxifloxacin Boron Complex Impurity
  • 6-cyclopropyl-8,9-difluoro-7-methoxy- 4-oxo-4,6-dihydro-2H-1l3,2l4- [1,3,2]dioxaborinino[5,6-c]quinoline- 2,2-diyl diacetate
  • Moxifloxacin INT-1 Impurity Control
  • Moxifloxacin EP Imp.INT-1
  • (T-4)-Bis(acetato-κO)[1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-(oxo-κO)-3-quinolinecarboxylato-κO3]boron
  • Azilsartan medoxomil impurity284
  • Moxifloxacin Intermediate I
  • Moxifloxacin Impurity INT-1
  • 6-cyclopropyl-8,9-difluoro
  • Moxifloxacin impurity 23/Moxifloxacin Boron Complex Impurity/6-cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H- 1l3,2l4-[1,3,2]dioxaborinino[5,6-c]quinoline-2,2-diyl diacetate
  • Moxifloxacin-8
  • 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid-O3,O4(bis(acyloxy-O)) borate
  • BALOFLOXACIN CHELATE
  • 6-Cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2H-1l3,2l4-[1,3,2]dioxaborinino[5,6-c]quinoline-2,2-diyl diacetate?(Moxifloxacin Impurity）
  • Moxifloxacin Impurity 12 CRS
  • 139693-52-0
Copyright 2019 © ChemicalBook. All rights reserved